Surmodics Sees FY24 Non-GAAP Diluted Loss Per Share To Range From $(1.32)-$(0.97) Vs. $(1.24) Estimate
Portfolio Pulse from Benzinga Newsdesk
Surmodics has projected its FY24 Non-GAAP diluted loss per share to range from $(1.32)-$(0.97), which is worse than the $(1.24) estimate.
November 08, 2023 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Surmodics' FY24 Non-GAAP diluted loss per share is expected to be worse than estimated, which could negatively impact the company's stock price.
Surmodics' projected FY24 Non-GAAP diluted loss per share is worse than the estimate. This indicates that the company's financial performance might not meet market expectations, which could lead to a decrease in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100